Consumer Health Neurology
- Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to mod...
June 08, 2023 | News
HanAll Biopharma Co., Ltd. (KRX: 009420.KS) and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620.KS) announced that they have entered into a co-developm...
May 26, 2023 | News
Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...
April 28, 2023 | News
Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and qualit...
March 31, 2023 | News
The program will enable Verbal Beginnings' clients, families, and caregivers to remotely report on the health outcomes that matter most to them, including ...
March 29, 2023 | News
Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received r...
March 27, 2023 | News
The Centers for Disease Control and Prevention (CDC) released today its update of autism's estimated prevalence among the nation's children, based on the a...
March 24, 2023 | News
Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel The Elecsys Amyloid Pla...
March 24, 2023 | News
Huntington's disease is a debilitating genetic disorder that affects the brain, causing gradual degeneration of nerve cells in specific areas of the brain,...
March 20, 2023 | News
One in five adults experiences neurodivergent conditions like Autism, ADHD, Tourette's, and OCD, and is more likely to avoid care due to previous negativ...
March 17, 2023 | News
Monitor blood pressure and predict a person's risk of pre-diabetes in just 30 seconds using only a smartphone video camera NuraLogix, a global pioneer of ...
February 27, 2023 | News
Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...
February 16, 2023 | News
The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CR...
February 15, 2023 | News
Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...
February 13, 2023 | News
Most Read
Bio Jobs
News